Compare SBI Healthcare Opportunities Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
1.93
2.27
NAV
₹429.11
₹280.31
Fund Started
04 Jun 1999
01 Aug 2005
Fund Size
₹3822.73 Cr
₹1055.01 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 30 days.
1 Year
8.54%
8.51%
3 Year
25.98%
25.13%
5 Year
17.17%
15.31%
Equity
98.53%
98.79%
Cash
1.39%
1.20%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Sun Pharmaceutical Industries Ltd. | 9.07% |
Ajanta Pharma Ltd. | 7.30% |
Lupin Ltd. | 6.02% |
Glenmark Pharmaceuticals Ltd. | 4.20% |
Gland Pharma Ltd. | 3.98% |
Alkem Laboratories Ltd. | 3.66% |
Apollo Hospitals Enterprise Ltd. | 3.50% |
Dr. Reddy's Laboratories Ltd. | 3.46% |
Procter & Gamble Health Ltd. | 3.02% |
Jupiter Life Line Hospitals Ltd. | 2.91% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Jun 1999
01 Aug 2005
